ECSP003743A - Profarmacos de higromicina a - Google Patents

Profarmacos de higromicina a

Info

Publication number
ECSP003743A
ECSP003743A EC2000003743A ECSP003743A ECSP003743A EC SP003743 A ECSP003743 A EC SP003743A EC 2000003743 A EC2000003743 A EC 2000003743A EC SP003743 A ECSP003743 A EC SP003743A EC SP003743 A ECSP003743 A EC SP003743A
Authority
EC
Ecuador
Prior art keywords
compounds
formula
propharms
hygromycin
infections
Prior art date
Application number
EC2000003743A
Other languages
English (en)
Inventor
Takushi Kaneko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP003743A publication Critical patent/ECSP003743A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Esta invención se refiere a compuestos de fórmula (gráfico), y a sales y solvatos farmacéuticamente aceptables de estos, siendo a,b,X, Y, Z, R1, R2 y R3 como se han definido en la descripción adjunta. Los compuestos de fórmula I son agentes antibacterianos y antiprotozoarios que pueden utilizarse para tratar infecciones bacterianas y protozoarias y enfermedades relacionadas con dichas infecciones. La invención se refiere también a composiciones farmacéuticas que contienen los compuestos de fórmula I y a procedimientos para tratar infecciones bacterianas y protozoarias mediante la administración de los compuestos de fórmula I.
EC2000003743A 1999-10-29 2000-10-27 Profarmacos de higromicina a ECSP003743A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16272299P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ECSP003743A true ECSP003743A (es) 2002-05-23

Family

ID=22586880

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2000003743A ECSP003743A (es) 1999-10-29 2000-10-27 Profarmacos de higromicina a

Country Status (32)

Country Link
US (1) US6492342B1 (es)
EP (1) EP1224194A1 (es)
JP (1) JP2003512472A (es)
KR (1) KR20020043255A (es)
CN (1) CN1382149A (es)
AP (1) AP2002002492A0 (es)
AR (1) AR026285A1 (es)
AU (1) AU7307900A (es)
BG (1) BG106635A (es)
BR (1) BR0015156A (es)
CA (1) CA2389019A1 (es)
CO (1) CO5261547A1 (es)
CZ (1) CZ20021347A3 (es)
EA (1) EA200200413A1 (es)
EC (1) ECSP003743A (es)
EE (1) EE200200226A (es)
GT (1) GT200000178A (es)
HK (1) HK1049844A1 (es)
HU (1) HUP0203223A2 (es)
IL (1) IL148580A0 (es)
IS (1) IS6312A (es)
MA (1) MA26839A1 (es)
MX (1) MXPA02004359A (es)
NO (1) NO20021822D0 (es)
OA (1) OA12079A (es)
PE (1) PE20010757A1 (es)
PL (1) PL357080A1 (es)
SK (1) SK5322002A3 (es)
SV (1) SV2002000210A (es)
TN (1) TNSN00209A1 (es)
TR (1) TR200201143T2 (es)
WO (1) WO2001030793A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020041179A1 (en) * 2018-08-20 2020-02-27 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3393189B2 (ja) * 1998-12-02 2003-04-07 ファイザー・プロダクツ・インク 抗菌薬としてのハイグロマイシンa誘導体

Also Published As

Publication number Publication date
SK5322002A3 (en) 2003-01-09
BG106635A (en) 2002-12-29
CZ20021347A3 (cs) 2002-11-13
PE20010757A1 (es) 2001-07-25
SV2002000210A (es) 2002-06-07
BR0015156A (pt) 2002-07-16
WO2001030793A1 (en) 2001-05-03
MA26839A1 (fr) 2004-12-20
KR20020043255A (ko) 2002-06-08
TR200201143T2 (tr) 2002-08-21
EP1224194A1 (en) 2002-07-24
EA200200413A1 (ru) 2002-10-31
CN1382149A (zh) 2002-11-27
EE200200226A (et) 2003-06-16
OA12079A (en) 2006-05-04
NO20021822L (no) 2002-04-18
HUP0203223A2 (en) 2003-02-28
AP2002002492A0 (en) 2002-06-30
AU7307900A (en) 2001-05-08
JP2003512472A (ja) 2003-04-02
MXPA02004359A (es) 2002-11-07
US6492342B1 (en) 2002-12-10
IS6312A (is) 2002-03-19
AR026285A1 (es) 2003-02-05
HK1049844A1 (zh) 2003-05-30
TNSN00209A1 (fr) 2005-11-10
NO20021822D0 (no) 2002-04-18
GT200000178A (es) 2002-04-09
PL357080A1 (en) 2004-07-12
IL148580A0 (en) 2002-09-12
CO5261547A1 (es) 2003-03-31
CA2389019A1 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
PA8486001A1 (es) Composiciones de celecoxib
BRPI0416692A (pt) inibidores heterocìclicos de mek e métodos de emprego destes
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
UY25780A1 (es) Nuevos antibióticos macrólidos
PA8489501A1 (es) Antibioticos cetolidos
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
ATE300541T1 (de) Pyrazolopyridinderivate
ES2182035T3 (es) Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa.
PA8471801A1 (es) Derivados de higromicina a
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
ECSP014093A (es) " derivados de higromicina a "
PA8471901A1 (es) Derivados de 2"-desoxi higromicina
AR019784A1 (es) Derivados de higromicina
SV2002000211A (es) Derivados de higromicina ref. pc10726abcz/bb
AR026285A1 (es) Profarmacos de higromicina a
UY26418A1 (es) Profarmacos de higromicina a
ECSP992931A (es) Derivados de 2'' desoxi higromicina
AR021816A1 (es) Antibioticos de carbamato y carbazato cetolida.
ECSP993239A (es) Derivados de higromicina
PA8505601A1 (es) Profarmacos de higromicina a
ECSP992943A (es) Derivados de higromicina a
ECSP993164A (es) Nuevos antibioticos macrolidos
ECSP003309A (es) Antibioticos cetolidos
UY26421A1 (es) Derivados de higromicina
ECSP993235A (es) Antibioticos cetolidos carbamato y carbazato